Restricted accessResearch articleFirst published online 1999-4
Preventable Methotrexate Toxicity ADRs Related to Ophthalmic Agents;Ophthalmic Adverse Effects Caused by Systemic Drugs ADRs with Antiretroviral Prophylaxis ADRS with Antimalarial Prophylaxis
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
Anonymous.Eye drops can cause systemic effects. Drugs Therapy Per-spect.1998; 12: 13–6.
2.
WolfhagenF.H.J.Severe nausea and vomiting with timolol eye drops. Lancet.1998; 352: 373.
GarbeE., SuissaS., LeLorierJ.Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA.1998; 280: 539–43.
5.
AquilinaC., VirabenR., RoueireA.Acute generalized exanthematous pustulosis—a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor. Arch Intern Med.1998; 158: 2160–1.
6.
AntonyS.J.Rapid development of indinavir-induced asymptomatic crystalluria in a human immunodeficiency virus-negative patient. Clin Infect Diseases.1998; 27: 911–2.
7.
ShusterJ.Hosp Pharm.1998; 33: 29.
8.
KatzM.H., GergerdingJ.L.The care of persons with recent sexual exposure to HIV. Ann Intern Med.1998; 128: 306–12.
9.
Prophylaxis after sexual exposure to HIV [letter]. Ann Intern Med.1998; 129: 671–2.
10.
OostweegelL.M.M., BeijnenJ.H., MulderJ.W.Hepatitis during chloroguanide prophylaxis. Ann Pharmacother.1998; 32: 1023–5.
11.
DavisT.M.E.Adverse effects of anti-malarial prophylactic drugs: An important consideration in the risk-benefit equation. Ann Pharmacother.1998; 32: 1104–6.
